摘要
Amniotic fluid embolism(AFE)is a rare but potentially lethal condition characterized by an abrupt onset,unpredictability,and high fatality rate.The Society forMaternal-FetalMedicine(SMFM)published clinical guideline No.9“Amniotic fluid embolism:diagnosis and management”in 2016.[1]Based on this guideline and other relevant studies,the Obstetrics Group of the Chinese Society of Obstetrics and Gynecology,Chinese Medical Association,developed a consensus on the diagnosis and treatment of AFE in December 2018,aiming to standardize its diagnosis and management,and to improve maternal and perinatal outcomes.
基金
This study was supported by a grant from the Scientific Research Seed Fund of Peking University First Hospital(No.2018SF017).
